Coronary artery disease (CAD) refers to a heart condition caused by plaque accumulation in the coronary arteries and is recognized as a significant risk factor for developing heart disease (
1). As the most prevalent form of heart disease, CAD has emerged as a primary cause of global mortality in recent decades (
2). According to 2015 statistics, cardiovascular diseases accounted for 17.7 million deaths worldwide, of which 7.4 million were attributed to coronary artery disease (
3). In Iran, as in many other countries, non-communicable diseases account for 70% of total deaths, with CAD alone contributing to 21% of mortality, making it the primary cause of death (
4). The prevalence of CAD has been increasing globally, affecting both developed and developing nations (
5). Studies indicate that worldwide CAD rates vary by age and gender, with rates between 11.9% for men and 10% for women aged 20 to 39 years, increasing to 84.7% in men and 85.9% in women over the age of 80 (
5). CAD continues to be the foremost cause of mortality worldwide (
6) and is also a major contributor to physical disability and reduced social participation (
7). This issue primarily stems from reduced physical fitness levels, which exert significant negative effects on patients' quality of life, social relationships, and occupational functioning (
7).
The benefits of physical activity (PA) in improving patient outcomes following acute coronary syndrome are now well-established. Studies clearly demonstrate that structured, supervised exercise-based cardiac rehabilitation programs can reduce mortality rates by up to 30% (
8). Furthermore, robust scientific evidence confirms that improved exercise capacity is linked to reduced overall mortality rates in this patient population (
9). Therefore, patients with CAD are advised to incorporate regular PA as a lasting lifestyle modification. To achieve optimal outcomes, PA should be combined with comprehensive lifestyle adjustments, including improved dietary patterns, stress management, and smoking cessation. Such multifactorial interventions optimize cardiovascular risk factors, ultimately enhancing physical capacity, social engagement, and quality of life.
A major challenge in secondary prevention for these patients lies in maintaining sustainable behavioral changes, particularly in adhering to regular PA after completing cardiac rehabilitation programs (
10). Current evidence indicates that despite participation in structured cardiac rehabilitation programs and receipt of specialized therapeutic education, the majority of patients fail to maintain recommended PA levels long-term (
11). This lack of sustained exercise engagement — a fundamental challenge in secondary prevention — likely stems from multiple barriers that diminish patients' motivation to continue exercise regimens. Emerging evidence suggests that even after considering objective factors such as comorbidities, age, exercise capacity, and sociodemographic characteristics, these variables only partially explain PA non-adherence (
12,
13). Subjective factors including perceived health status, self-care abilities, and depression/anxiety symptoms appear to exert comparable — if not greater — influence on PA maintenance than actual health status (
12,
13). These modifiable factors can be positively addressed through behavioral interventions targeting exercise adherence barriers. However, effective intervention design requires preliminary identification of the most significant barriers to consistent PA among these individuals (
14). This constitutes a critical first step in developing targeted solutions.
Notably, unlike diabetes management where validated assessment tools exist (
15), there is currently no standardized clinical instrument for rapid and reliable evaluation of these barriers among CAD patients. This investigation sought to develop and validate a practical instrument for evaluating perceived obstacles to consistent exercise among individuals with CAD. The instrument's development enables the recognition of potential intervention targets and facilitates tailored clinical monitoring strategies for secondary prevention initiatives. The evaluation of physical activity barriers holds significance for both therapeutic management and lifestyle enhancement. However, the absence of validated physical activity barrier assessments specifically for CAD patients underscores the necessity of examining this questionnaire's measurement properties within Iran's population.